Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$544K Buy
4,128
+541
+15% +$63.3K 0.04% 362
2026
Q1
$392K Sell
3,587
-454
-11% -$52.4K 0.03% 404
2025
Q4
$448K Sell
4,041
-401
-9% -$37.6K 0.04% 370
2025
Q3
$383K Sell
4,442
-37
-0.8% -$3.05K 0.03% 391
2025
Q2
$364K Buy
4,479
+712
+19% +$56.6K 0.04% 369
2025
Q1
$294K Buy
3,767
+99
+3% +$9.24K 0.04% 381
2024
Q4
$365K Buy
+3,668
New +$378K 0.05% 309

Other funds holding MRK

Sovran Advisors's MRK Position: Q2 2026 in Review

Sovran Advisors increased its Merck (MRK) stake by 15% in Q2 2026, buying an estimated $63.3K and bringing the position to 4,128 shares worth $544K. The position accounts for 0.04% of the portfolio, ranked #362.

Sovran Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,766 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sovran Advisors held 4,128 shares of Merck worth $544K as of Q2 2026.
  • Sovran Advisors bought 541 Merck shares in Q2 2026, an estimated $63.3K.
  • Merck made up 0.04% of Sovran Advisors's portfolio in Q2 2026, its #362 holding.
  • Sovran Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,766 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sovran Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.